Patients with different chronic pain diagnoses recorded similar brain changes, a new study finds, suggesting a need for new treatment approaches.
Experts have provided new guidance in the use of contrast agents during MRI scans. Emerging research suggests gadolinium-based contrast agents, injected in a patient’s veins to brighten tissues in MRI images, accumulate in the brain. More than 300 million doses of such drugs have been administered since their introduction in 1987.
Structural and functional MRI in children resuscitated after drowning pinpoints the site of anoxic brain injury to regions controlling movement, while providing strong evidence that networks controlling perception and cognition remain largely intact.
Using three-dimensional magnetic resonance imaging, a research team characterized the shape, volume, morphometry and texture of placentas during pregnancy and, using a novel framework, predicted with high accuracy which pregnancies would be complicated by fetal growth restriction.
Experiments in dogs, rabbits and monkeys show the efficacy and biocompatibility of a new MRI/MRA contrast agent in detecting stroke. This T1 MRI contrast agent based on ultrasmall iron oxide nanoparticles could become a possible alternative to clinically used gadolinium-based agents.
Using the latest techniques, MRI can provide a ‘one-stop-shop’ method for evaluation of potential living liver donors, according to an article.
Images of the brain’s gray and white matter obtained with multiple MRI techniques can help identify and track cognitive impairment in active professional fighters, according to a new study.
A human protein-based, tumor-targeting Magnetic Resonance Imaging (MRI) contrast has been developed that can be easily cleared by the body. The discovery holds promise for clinical application.